Chemomab Therapeutics Ltd.
CMMB- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001534248
In the last 90 days, Chemomab Therapeutics Ltd. insiders filed 0 open-market purchases and 1 sale; 13 institutions reported holding it in 13F filings for Q2 2026, worth $615.3K in total; no superinvestor holds it.
Holders of 5% or more of CMMB
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Chemomab Therapeutics Ltd., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Otto Erik | 13G/A | 8.10%1.69M shares | – | Aug 11, 20251 filing | Aug 11, 2025 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
5 Schedule 13D and 13G filings on Chemomab Therapeutics Ltd., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Aug 11, 20251:04 PM ET | Otto Erik | 13G/A | 8.10%1.69M shares | – | Aug 11, 2025 | SEC |
| Aug 7, 20254:21 PM ET | Morgan Stanleyand 1 other | 13G/A | 3.20%13.2M shares | −5.20 ppfrom 8.40%Below 5% | Jul 31, 2025 | SEC |
| Aug 7, 202511:45 AM ET | Morgan Stanleyand 1 other | 13G | 8.40%32.3M shares | New | Jun 30, 2025 | SEC |
| Jun 23, 20255:06 PM ET | OrbiMed Israel BioFund GP Limited Partnershipand 3 others | 13D/A | 4.80%969.8K shares | –Below 5% | Jun 18, 2025 | SEC |
| Apr 10, 20255:25 PM ET | Sphera Funds Management Ltd.and 2 others | 13G/A | 4.78%900.4K shares | –Below 5% | Mar 31, 2025 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Chemomab Therapeutics Ltd. shares.
No Form 144 notices for Chemomab Therapeutics Ltd. are on file.